Cardiotoxicity clinical trials at UC Health
1 research study open to eligible people
Experimental Treatment With "Carvedilol" to Avoid Heart Problems in Patients With HER-2-Positive Breast Cancer That Has Spread
“This study will test whether carvedilol can reduce heart problems during your cancer treatment.”
open to eligible people ages 18 years and up
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
at UC Davis